Search
02/12/2022
Biologic treatment of psoriasis in oncologic patients
Rusinol, L, Camina-Conforto, G, Puig, L. Biologic treatment of psoriasis in oncologic patients. EXPERT OPINION ON BIOLOGICAL THERAPY. 2022; 22(12)DOI:10.1080/14712598.2022.2152322. PMID:36422998. IF:4.600(Q2/3D).
01/11/2022
Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study
Lopez-Ferrer, A, Vilarrasa, E, Armesto, S, Santos-Juanes, J, Galache, C, Carretero, G, Sahuquillo, A, Salgado-Boquete, L, del Alcazar, E, Gonzalez-Cantero, A, Martorell, A, Rivera-Diaz, R, Mitxelena-Ezeiza, J, Mateu, A, Belinchon, I, Llamas-Velasco, M, Riera-Monroig, J, Lazaro, A, Lopez-Estebaranz, JL, Gich, I, Puig, L. Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study. Dermatologic Therapy. 2022; 35(11)DOI:10.1111/dth.15831. PMID:36109488. IF:3.600(Q1/3D).
01/09/2022
Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting
Reolid, A, Armesto, S, Sahuquillo-Torralba, A, Torres, T, Feltes, R, Vilarrasa, E, Belincho, I, de la Cueva, P, Rodriguez, L, Romero-Mate, A, Vidal, D, Coto-Segura, P, Herrera-Acosta, E, Riera-Monroig, J, Salgado, L, Llamas-Velasco, M, Dauden, E. Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2022; 87(3)DOI:10.1016/j.jaad.2022.05.047. PMID:35640798. IF:13.800(Q1/1D).
01/09/2022
SARS-CoV-2 seroprevalence in blood donors before and after the first wave in Catalonia (Spain)
Piron, M, Jane, M, Ciruela, P, Basile, L, Martinez, A, Puig, L, Bes, M, Sauleda, S. SARS-CoV-2 seroprevalence in blood donors before and after the first wave in Catalonia (Spain). Blood Transfusion. 2022; 20(5)DOI:10.2450/2022.0232-21. PMID:35175189. IF:3.700(Q2/4D).
08/07/2022
Psoriatic arthritis
Lopez-Ferrer, A, Laiz, A, Puig, L. Psoriatic arthritis. MEDICINA CLINICA. 2022; 159(1)DOI:10.1016/j.medcli.2022.01.024. PMID:35525675. IF:3.900(Q2/4D).
01/06/2022
[Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2-Management of Special Populations, Patients With Comorbid Conditions, and Risk
Carrascosa, JM, Puig, L, Romero, IB, Salgado-Boquete, L, del Alcazar, E, Lencina, JJA, Moreno, D, de la Cueva, P. [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2-Management of Special Populations, Patients With Comorbid Conditions, and Risk. Actas Dermo-Sifiliograficas. 2022; 113(6)DOI:10.1016/j.ad.2022.01.024. PMID:35748004. IF:(Q/D).